Involvement of Erythropoietin Expression in Acupuncture Preconditioning-Induced Ischemic Tolerance

Abstract:

Abstract Objective To investigate the expression of erythropoietin (EPO) after acupuncture preconditioning plus focal cerebral ischemia treatment. Methods Rat focal cerebral ischemia model and acupuncture preconditioning model were established. Animals were randomly assigned into different groups: control (focal cerebral ischemia) and acupuncture preconditioning plus focal cerebral ischemia, with 8 rats for each group. The expression of EPO after different treatments was determined by histological examination, immunohistochemistry and in situ hybridization. Results The mRNA and protein expressions of EPO could be detected in survival and necrotic neurons, glia as well as vascular endothelial cells. Focal cerebral ischemia promoted the expression of EPO. Significant enhanced EPO level was found in the ischemic peripheral zone after acupuncture preconditioning (P < 0.05). Conclusion Our results demonstrated that acupuncture preconditioning enhanced the expression of EPO in neurons, glia and vascular endothelial cells the ischemic peripheral zone, suggesting the involvement of EPO in acupuncture preconditioning-induced neuroprotection following focal cerebral ischemia. EPO may exert neuroprotective effects through promoting neurotrophic support and angiogenesis.

• Periodical: Advanced Materials Research (Volumes 554-556)
• Pages: 1650-1655
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.554-556.1650
• Online since: July 2012
• Authors: Xue Mei Han, Hong Tao Wei, Song Yan Liu
• Keywords: Acupuncture Preconditioning, Cerebral Ischemia, EPO

References

[1] Longa EZ, Weintein PR, Carson S, et al. Reversible middle cerebral aetery occlusion without crainietomy in rats [J]. Stroke, 1989, 20(1): 84-91.

DOI: 10.1161/01.str.20.1.84

[2] Stroda DM, Burkhardt T, Desbaillets I et al.HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J, 2001; 15(13):2445-2453

DOI: 10.1096/fj.01-0125com

[3] Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11:4159–4170

DOI: 10.1046/j.1460-9568.1999.00845.x

[4] Chen ZB, Yuan F, Liang FX, et al. Effect of brain tissue extract after acupuncture preconditioning on cerebral ischemia-reperfusion injury in rats. Chinese Acupuncture & Moxibustion 2004, 24 (5):347-350.

[5] Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, UnzickerC, Sirén AL, Ehrenreich H (2000) Survival of hippocampalneurons in culture upon hypoxia: effect of erythropoietin. Neuroreport11: 3485–3488

DOI: 10.1097/00001756-200011090-00017

[6] Sakanaka M, Wen TC, Matsuda S,Masuda S,Morishita E, NagaoM, Sasaki R (1998) In vivo evidence that erythropoietin protectsneurons from ischemic damage. Proc Natl Acad Sci U S A 95:4635–4640

DOI: 10.1073/pnas.95.8.4635

[7] Marti HH, Wenger LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8:666-676

DOI: 10.1111/j.1460-9568.1996.tb01252.x

[8] Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R(1994) A novel site of erythropoietin production.Oxygen-dependentproduction in cultured rat astrocytes. J Biol Chem 269:19488–19493

DOI: 10.1016/s0021-9258(17)32195-6

[9] Juul SE, Anderson DK, Li Y, Chriestensen RD (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49

DOI: 10.1203/00006450-199801000-00007

[10] Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720

DOI: 10.1073/pnas.92.9.3717

[11] Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM,Cerami A (2000) From the cover: erythropoietincrosses the blood-brain barrier to protect against experimentalbrain injury. Proc Natl Acad Sci U S A 97: 10526–1053

DOI: 10.1073/pnas.97.19.10526

[12] Karsten R, Dorette F, Maria K, et al. Erythropoietin is a paracrine mediator of ischemia tolerance in the brain:evidence from an in vitro model.The J of Neurosci, 2002, 22(23):10291-10301

DOI: 10.1523/jneurosci.22-23-10291.2002

[13] Sirén A-L, Fratelli M, Brines ML,Goemans C, Casagrande S,LewczukP, Keenan S, Gleiter C, Pasquali C, Capobianco A,MenniniT, Heumann R, Cerami A, Ehrenreich H, Ghezzi P (2001 a) Erythropoietinprevents neuronal apoptosis after cerebral ischemiaand in metabolically stressed neurons. Proc Natl Acad Sci U S A98: 4044–4049.

DOI: 10.1073/pnas.051606598

[14] Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997; 76: 105–116.

DOI: 10.1016/s0306-4522(96)00306-5

[15] Sinor AD, Greenberg DA (2000) Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 290:213–215

DOI: 10.1016/s0304-3940(00)01361-6

[16] Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K,Nakano Y (1996) Brain capillary endothelial cells express twoforms of erythropoietin receptor mRNA. Eur J Biochem 239:494–500

DOI: 10.1111/j.1432-1033.1996.0494u.x

[17] Wang, L., et al. , Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab, 2008. 28(7): pp.1361-8

DOI: 10.1038/jcbfm.2008.32